{"product_id":"sustainable-nanomaterials-for-treatment-and-diagnosis-of-infectious-diseases","title":"Sustainable Nanomaterials for Treatment and Diagnosis of Infectious Diseases","description":"\u003cdiv id=\"bookDescription_feature_div\" class=\"celwidget\" data-feature-name=\"bookDescription\" data-csa-c-type=\"widget\" data-csa-c-content-id=\"bookDescription\" data-csa-c-slot-id=\"bookDescription_feature_div\" data-csa-c-asin=\"0993745598\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-id=\"7y9w7h-rgk3d4-2xixgp-6jetc1\" data-cel-widget=\"bookDescription_feature_div\"\u003e\n\u003cdiv data-a-expander-name=\"book_description_expander\" data-a-expander-collapsed-height=\"280\" class=\"a-expander-collapsed-height a-row a-expander-container a-spacing-base a-expander-partial-collapse-container\"\u003e\n\u003cdiv aria-expanded=\"false\" class=\"a-expander-content a-expander-partial-collapse-content\"\u003e\n\u003cdiv data-cel-widget=\"bookDescription_feature_div\" data-csa-c-id=\"d89ima-g32k3-dt8on3-pksk48\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-asin=\"052173648X\" data-csa-c-slot-id=\"bookDescription_feature_div\" data-csa-c-content-id=\"bookDescription\" data-csa-c-type=\"widget\" data-feature-name=\"bookDescription\" class=\"celwidget\" id=\"bookDescription_feature_div\"\u003e\n\u003cdiv class=\"a-expander-collapsed-height a-row a-expander-container a-spacing-base a-expander-partial-collapse-container\" data-a-expander-collapsed-height=\"280\" data-a-expander-name=\"book_description_expander\"\u003e\n\u003cdiv class=\"a-expander-content a-expander-partial-collapse-content\" data-expanded=\"false\"\u003e\n\u003cdiv class=\"accordion-item\" id=\"acc-description\"\u003e\n\u003cdiv id=\"flush-collapseTwo\" class=\"accordion-collapse collapse show\" aria-labelledby=\"flush-headingTwo\"\u003e\n\u003cdiv class=\"accordion-body description\"\u003e\n\u003cp\u003e\u003cb\u003eThe book focuses on the design and novel synthetic routes of sustainable nanomaterials in diagnosing and treating infectious diseases offering potential benefits in terms of efficiency, biocompatibility, and environmental impact.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe fifteen chapters in this book provide a comprehensive exploration of how sustainable nanotechnology can revolutionize infectious disease management and bridge the gap between the fundamental principles of nanotechnology and their practical applications in combating infectious diseases. Subjects covered include: the rise of multidrug-resistant pathogens and the limitations of existing therapies; the challenges of infectious disease management including the rise of multidrug-resistant pathogens and the limitations of existing therapies; nano-pharmacology and pharmacotherapeutics in the treatment of infectious diseases; the advancements in nanomaterial-based drug delivery systems, vaccines, and diagnostic tools, and the future of personalized medicine; nanotheranostic mechanisms outlining how nanomaterials can be engineered to simultaneously diagnose and treat infections; nano drug delivery systems that contribute to enhancing the efficacy and precision of treatment modalities; biocompatibility and toxicity of nanomaterials in the diagnosis and treatment of infectious diseases; regulatory perspectives of nanomaterials ensuring they meet safety and efficacy standards; green synthesis of reduced graphene oxide, carbon dots, and its composites for infectious diseases and biosurfactants; nanomaterials of polymeric design underscoring their potential to create more effective and sustainable therapeutic options; how nanomaterials can be engineered to simultaneously diagnose and treat infections.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eAudience\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe book targets nanotechnology researchers, scientists, and healthcare professionals interested in understanding nanotechnology’s critical role in sustainable healthcare solutions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cdiv class=\"aboutauthors-section\" id=\"aboutauthors-section\"\u003e\n\u003cdiv class=\"page-section\"\u003e\n\u003cdiv class=\"section-title collapsed\" data-toggle=\"collapse\"\u003eAbout the Author\u003c\/div\u003e\n\u003cdiv class=\"section-content collapsed\"\u003e\n\u003cp\u003e\u003cb\u003eRajasekhar Chokkareddy, PhD,\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eis an associate in the Department of Chemistry, Aditya College of Engineering, Andhra Pradesh, India. His primary research interests span the development of electrochemical sensors and biosensors for various pharmaceutical drugs, the green synthesis of nanoparticles, separation techniques, and the synthesis of ionic-functionalized nanocomposites. He has authored more than 30 research articles.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSuvardhan Kanchi, PhD,\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eis an associate professor in the Department of Chemistry at CHRIST (Deemed to be University), Bengaluru, India. He is dedicated to the field of chemistry, with a particular focus on nanoelectrochemistry and separation sciences.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eGan G Redhi, PhD,\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eis Professor Emeritus and former head of the Chemistry Department at Durban University of Technology, Durban, South Africa. He has published more than 100 research papers in peer-reviewed journals and his main research interests are in physical and electroanalytical chemistry.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tableofcontents-section\" id=\"tableofcontents-section\"\u003e\n\u003cdiv class=\"page-section\"\u003e\n\u003cdiv class=\"section-title collapsed\" data-toggle=\"collapse\"\u003eTable of Contents\u003c\/div\u003e\n\u003cdiv class=\"section-content collapsed\"\u003e\n\u003cp\u003ePreface xvii\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e1 Introduction of Sustainable Nanotechnology and Its Potentiality 1\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSandeep Yadav, Prashant Singh, Pallavi Jain, Kamlesh Kumari, Bakusele Kabane, Lebogang Maureen Katata-Seru and Indra Bahadur\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e1.1 Introduction 2\u003c\/p\u003e\n\u003cp\u003e1.2 Principles of Sustainable Nanotechnology 3\u003c\/p\u003e\n\u003cp\u003e1.3 Applications of Sustainable Nanotechnology 6\u003c\/p\u003e\n\u003cp\u003e1.4 Conclusion 17\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e2 A Review on Infectious Disease Management and Their Challenges 23\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eDasari Sravani\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e2.1 Infectious Diseases 23\u003c\/p\u003e\n\u003cp\u003e2.2 Types of Infectious Illnesses 24\u003c\/p\u003e\n\u003cp\u003e2.3 Epidemics Diseases in 19th Century 26\u003c\/p\u003e\n\u003cp\u003e2.4 Disease Epidemics in the 20th Century 29\u003c\/p\u003e\n\u003cp\u003e2.5 Epidemics Diseases in 21st Century 30\u003c\/p\u003e\n\u003cp\u003e2.6 Vaccination for Humans 30\u003c\/p\u003e\n\u003cp\u003e2.7 Results and Discussion 31\u003c\/p\u003e\n\u003cp\u003e2.8 Challenges Faced by People Due to Sudden Microbial Outbreaks 35\u003c\/p\u003e\n\u003cp\u003e2.9 Recommendations for the Global Community 38\u003c\/p\u003e\n\u003cp\u003e2.10 Measures for Prevention of Infectious Diseases Threats 42\u003c\/p\u003e\n\u003cp\u003e2.11 Authors Contributions 42\u003c\/p\u003e\n\u003cp\u003e2.12 Acknowledgements 43\u003c\/p\u003e\n\u003cp\u003e2.13 Conclusions 43\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e3 Challenges in Infectious Disease Management 51\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAishwarya Rathore, Sheelu Sharma and Manu Sharma\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e3.1 Introduction 52\u003c\/p\u003e\n\u003cp\u003e3.2 Challenges Faced to Control Infectious Disease 52\u003c\/p\u003e\n\u003cp\u003e3.3 Global Warming and Its Impact on the Management of Infectious Diseases 60\u003c\/p\u003e\n\u003cp\u003e3.4 Antibiotic Resistance 61\u003c\/p\u003e\n\u003cp\u003e3.5 Demographic Shift and Aging Population 65\u003c\/p\u003e\n\u003cp\u003e3.6 Modern Food Technology as a Threat 65\u003c\/p\u003e\n\u003cp\u003e3.7 Key to Overcome the Challenges 67\u003c\/p\u003e\n\u003cp\u003e3.8 Conclusion 70\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e4 Nanopharmacology and Pharmacotherapeutics 81\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSulochana G., Rajeshkumar S. and Prabhu Manickam Natarajan\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003eAbbreviations 82\u003c\/p\u003e\n\u003cp\u003e4.1 Introduction 83\u003c\/p\u003e\n\u003cp\u003e4.2 Method of Synthesis 84\u003c\/p\u003e\n\u003cp\u003e4.3 Different Classes of Nanoparticles 87\u003c\/p\u003e\n\u003cp\u003e4.4 Fundamental Concepts of Pharmacology 90\u003c\/p\u003e\n\u003cp\u003e4.5 Route of Administration 94\u003c\/p\u003e\n\u003cp\u003e4.6 Interaction Within the Body Pharmacotherapeutic of the Nanoparticles 95\u003c\/p\u003e\n\u003cp\u003e4.7 Potential Drug Delivery System 99\u003c\/p\u003e\n\u003cp\u003e4.8 Toxicity of Nanoparticles 101\u003c\/p\u003e\n\u003cp\u003e4.9 Conclusion 104\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e5 Vaccines, Diagnosis, and Treatment of Infectious Diseases 113\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eK. Ganesh Kadiyala, Kommuru Goutham, Naresh Kumar Katari and Yamini Vanipenta\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e5.1 Introduction 114\u003c\/p\u003e\n\u003cp\u003e5.2 Contemporary Methods for Combating Infectious Disease 115\u003c\/p\u003e\n\u003cp\u003e5.3 Focusing and Implementing Specialized Assistance for Infection Control 115\u003c\/p\u003e\n\u003cp\u003e5.4 Prominence of Prompt Discrepancy Diagnosis in Infection Control 116\u003c\/p\u003e\n\u003cp\u003e5.5 The Immune System 130\u003c\/p\u003e\n\u003cp\u003e5.6 Conclusion 136\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e6 Society Strategies in Infectious Diseases 139\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAnirudh Pratap Singh Raman, Prashant Singh, Pallavi Jain, Kamlesh Kumari, Bakusele Kabane and Indra Bahadur\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e6.1 Introduction 140\u003c\/p\u003e\n\u003cp\u003e6.2 Combating Emerging Infections of COVID-19--Strategies and Response Capacities 142\u003c\/p\u003e\n\u003cp\u003e6.3 Candida albicans 145\u003c\/p\u003e\n\u003cp\u003e6.4 Black Fungus 146\u003c\/p\u003e\n\u003cp\u003e6.5 Typhoid 147\u003c\/p\u003e\n\u003cp\u003e6.6 Tuberculosis (TB) 148\u003c\/p\u003e\n\u003cp\u003e6.7 Conclusion 150\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e7 Nanotheranostic Mechanism against Infectious Diseases 155\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eTharani M. and Rajeshkumar S.\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e7.1 Introduction 156\u003c\/p\u003e\n\u003cp\u003e7.2 Nanomaterials as an Emerging Promising Tool 157\u003c\/p\u003e\n\u003cp\u003e7.3 Nanotheranostics 158\u003c\/p\u003e\n\u003cp\u003e7.4 Infectious Diseases 158\u003c\/p\u003e\n\u003cp\u003e7.5 Drug Delivery Challenges in Infectious Diseases 160\u003c\/p\u003e\n\u003cp\u003e7.6 Nanotheranostic Applications for Treating Infectious Diseases 162\u003c\/p\u003e\n\u003cp\u003e7.7 Diagnostic Imaging Contrast Agents 164\u003c\/p\u003e\n\u003cp\u003e7.8 Advantages of Nanotheranostics for Infectious Diseases 167\u003c\/p\u003e\n\u003cp\u003e7.9 Challenges and Limitations of Nanotheranostics 172\u003c\/p\u003e\n\u003cp\u003e7.10 Conclusion 173\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e8 Trends in Nano Drug Delivery System for Infectious Diseases 181\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRutuja Shah, Sameer Nadaf, Durgacharan Bhagwat and Shailendra Gurav\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e8.1 Background of Infectious Diseases 182\u003c\/p\u003e\n\u003cp\u003e8.2 Current Treatments for Infectious Diseases 183\u003c\/p\u003e\n\u003cp\u003e8.3 Drawbacks of Current Treatments 185\u003c\/p\u003e\n\u003cp\u003e8.4 Nanotechnology 187\u003c\/p\u003e\n\u003cp\u003e8.5 Application of Nanotechnology in Treating Infectious Diseases 189\u003c\/p\u003e\n\u003cp\u003e8.6 Future Prospects and Challenges 195\u003c\/p\u003e\n\u003cp\u003e8.7 Conclusion 202\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e9 Sustainable Nanotechnology and Multidrug Resistance toward the Pathogens of Infectious Diseases 207\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eEswara Rao Puppala and Vaskuri G. S. Sainaga Jyothi\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e9.1 Introduction 208\u003c\/p\u003e\n\u003cp\u003e9.2 Causes and Concerns of MDR 209\u003c\/p\u003e\n\u003cp\u003e9.3 Mechanism of MDR in Pathogens 211\u003c\/p\u003e\n\u003cp\u003e9.4 Nanomaterials Exhibiting Antimicrobial Properties 216\u003c\/p\u003e\n\u003cp\u003e9.5 Nanocarrier-Based Approach to Combat MDR 229\u003c\/p\u003e\n\u003cp\u003e9.6 Conclusion 239\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e10 Trends in Development of Multidrug Resistance Toward to the Pathogens of Infectious Diseases by Sustainable Nanotechnology 251\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMridula Sreedharan, Sushma Narayanan, Sabu Thomas, Yves Grohens and Nandakumar Kalarikkal\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e10.1 Introduction 252\u003c\/p\u003e\n\u003cp\u003e10.2 Current Threats in Clinics due to Multidrug Resistance 252\u003c\/p\u003e\n\u003cp\u003e10.3 Mechanism of Drug Resistance in Bacteria 254\u003c\/p\u003e\n\u003cp\u003e10.4 Nanoparticles and Their Antimicrobial Action 257\u003c\/p\u003e\n\u003cp\u003e10.5 Properties of Nanoparticles which Effect Bacterial Growth 259\u003c\/p\u003e\n\u003cp\u003e10.6 Commonly Utilized Metal Nanoparticles 260\u003c\/p\u003e\n\u003cp\u003e10.7 Nanoparticles as Carriers of Antibiotics 261\u003c\/p\u003e\n\u003cp\u003e10.8 Novel Nano Drug Delivery Systems 262\u003c\/p\u003e\n\u003cp\u003e10.9 Challenges and Future Prospects in Using Nanoparticles as Antimicrobials 264\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e11 Exploration of Biocompatibility and Toxicity of Nanomaterials in Diagnosis and Treatment of Infectious Diseases 269\u003c\/b\u003e\u003cbr\u003e\u003ci\u003ePuvvada Nagaprasad, Basavaiah Chandu and Pravas Kumar Panigrahi\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e11.1 Introduction 270\u003c\/p\u003e\n\u003cp\u003e11.2 Organic Nanoparticles 270\u003c\/p\u003e\n\u003cp\u003e11.3 Inorganic Nanoparticles 277\u003c\/p\u003e\n\u003cp\u003e11.4 Sustained Systemic Delivery of Anti-Infectives 281\u003c\/p\u003e\n\u003cp\u003e11.5 Nanomaterials Role in Infection Diseases 284\u003c\/p\u003e\n\u003cp\u003e11.6 Treatment for Arthritis Inflammation 295\u003c\/p\u003e\n\u003cp\u003e11.7 Other Viruses 296\u003c\/p\u003e\n\u003cp\u003e11.8 Nanovaccines 298\u003c\/p\u003e\n\u003cp\u003e11.9 Nanoparticles Biodegradation and Elimination 299\u003c\/p\u003e\n\u003cp\u003e11.10 Toxicity 300\u003c\/p\u003e\n\u003cp\u003e11.11 Limitations of Nanoparticles as Therapeutics 301\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e12 Regulatory Perspectives of Nanomaterials in the Treatment and Diagnosis of Infectious Dental Diseases 311\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eHarmesh Lal Chouhan, Sakshi Joshi, Shikha Dogra, Rini Chacko, Parika Vaid and Arunima Guru\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e12.1 Introduction 312\u003c\/p\u003e\n\u003cp\u003e12.2 Nanoparticles Used in Dentistry 313\u003c\/p\u003e\n\u003cp\u003e12.3 Nanotechnology Used for Diagnosis 316\u003c\/p\u003e\n\u003cp\u003e12.4 Nanoparticles in the Treatment of Infectious Diseases 317\u003c\/p\u003e\n\u003cp\u003e12.5 Conclusion 322\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e13 Green Synthesis of Reduced Graphene Oxide, Carbon Dots, and Its Composites for Infectious Diseases 327\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eGangaraju Gedda, Ganesh Gollavelli and Sarojani Kommoju\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e13.1 Introduction 328\u003c\/p\u003e\n\u003cp\u003e13.2 Green Synthesis of Reduced Graphene Oxide and Graphene Oxide Nanocomposites 329\u003c\/p\u003e\n\u003cp\u003e13.3 Antibacterial Activity 330\u003c\/p\u003e\n\u003cp\u003e13.4 Green Synthesis of Carbon Dots 338\u003c\/p\u003e\n\u003cp\u003e13.5 Antibacterial Activity of CDs 341\u003c\/p\u003e\n\u003cp\u003e13.6 Antifungal Activity of CDs 347\u003c\/p\u003e\n\u003cp\u003e13.7 Antiviral Activity of CDs 349\u003c\/p\u003e\n\u003cp\u003e13.8 Conclusions and Future Perspectives 352\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e14 Biosurfactants: Production Methods, Properties and Their Applications in Food Industry 365\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eManu Sharma, Aishwarya Rathore, Sheelu Sharma, Veera Sadhu and Kakarla Raghava Reddy\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e14.1 Introduction 366\u003c\/p\u003e\n\u003cp\u003e14.2 Classification of Biosurfactants 367\u003c\/p\u003e\n\u003cp\u003e14.3 Method of Production of Biosurfactants from Microorganisms 369\u003c\/p\u003e\n\u003cp\u003e14.4 Mechanism of Action 369\u003c\/p\u003e\n\u003cp\u003e14.5 Economics in Production of Biosurfactants 372\u003c\/p\u003e\n\u003cp\u003e14.6 Use of Yeast Over Bacteria 373\u003c\/p\u003e\n\u003cp\u003e14.7 Properties of Biosurfactants Used in the Food Industry 377\u003c\/p\u003e\n\u003cp\u003e14.8 Application of Biosurfactant in the Food Industry 379\u003c\/p\u003e\n\u003cp\u003e14.9 Conclusions 383\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e15 Nanomaterials of Polymeric Design for the Treatment of Infectious Diseases 393\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eK. Ganesh Kadiyala, Kommuru Goutham, Naresh Kumar Katari and Yamini Vanipenta\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e15.1 Introduction 394\u003c\/p\u003e\n\u003cp\u003e15.2 Malaria 396\u003c\/p\u003e\n\u003cp\u003e15.3 Tuberculosis 399\u003c\/p\u003e\n\u003cp\u003e15.4 Cholera 402\u003c\/p\u003e\n\u003cp\u003e15.5 Polymeric Nanomaterial to Treat Pulmonary Infections 404\u003c\/p\u003e\n\u003cp\u003e15.6 Nanoparticles Coated with Polymers to Treat Urinary Tract Infections 405\u003c\/p\u003e\n\u003cp\u003e15.7 HIV 409\u003c\/p\u003e\n\u003cp\u003e15.8 Hepatitis B 411\u003c\/p\u003e\n\u003cp\u003e15.9 COVID-19 413\u003c\/p\u003e\n\u003cp\u003e15.10 Zika Virus 416\u003c\/p\u003e\n\u003cp\u003e15.11 Influenza 419\u003c\/p\u003e\n\u003cp\u003e15.12 Polymeric Nanoparticles for Neuro-Infections 421\u003c\/p\u003e\n\u003cp\u003e15.13 Conclusion and Future Trends 424\u003c\/p\u003e\n\u003cp\u003eReferences 425\u003c\/p\u003e\n\u003cp\u003eIndex 437\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"a-section a-spacing-small a-padding-small\"\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cb\u003eBOOKREAD™ 5-STEP SATISFACTION GUARANTEE\u003c\/b\u003e\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003e1. No Risk, 30-Day Money-Back Guarantee. \u003cbr\u003e2. instant download. No surprises or hidden fees.\u003cbr\u003e3. Safe Payments via Credit\/Debit Card or PayPal® \u003cbr\u003e4. McAfee™ and SSL secured shopping cart.\u003cbr\u003e5. lifetime customer support.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"PDF","offer_id":56778134683979,"sku":null,"price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1031\/1204\/8971\/files\/1394200013.webp?v=1773316635","url":"https:\/\/bookread.io\/products\/sustainable-nanomaterials-for-treatment-and-diagnosis-of-infectious-diseases","provider":"bookread","version":"1.0","type":"link"}